Fred Alger Management’s CervoMed CRVO Stock Holding History

Fred Alger Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,500	Closed	-$59.9K	–	448
2024 Q2	$59.9K	Buy	+3,500	New	+$76.5K	﹤0.01%	410

Other funds holding CRVO

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return

Fred Alger Management's CRVO Position: Q3 2024 in Review

Fred Alger Management sold out of CervoMed (CRVO) in Q3 2024, closing a stake of 3,500 shares — an estimated $59.9K sold.

Fred Alger Management first reported a position in CRVO in Q2 2024 and held it in 1 quarter. The position peaked at $59.9K in Q2 2024. 50 funds tracked by Wall St. Rank hold CRVO as of Q3 2024.

Fred Alger Management reported no remaining CervoMed position as of Q3 2024 after selling out during the quarter.
Fred Alger Management sold 3,500 CervoMed shares in Q3 2024, an estimated $59.9K.
Fred Alger Management first reported a position in CervoMed in Q2 2024 and held it in 1 quarter.
Fred Alger Management's CervoMed position peaked at $59.9K in Q2 2024.
50 funds tracked by Wall St. Rank held CervoMed as of Q3 2024.

Based on Fred Alger Management's 13F filing for Q3 2024, filed 14 Nov 2024.